Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders (Q38091301)

28 August 2017

Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders (English)

1 reference

28 August 2017

1 reference

Rafael Tabarés-Seisdedos

series ordinal

1

object named as

Rafael Tabarés-Seisdedos

1 reference

28 August 2017

John L Rubenstein

2

1 reference

PubMed ID

23511909

28 August 2017

language of work or name

English

0 references

publication date

1 April 2013

1 reference

Nature Reviews Neuroscience

28 August 2017

1 reference

28 August 2017

14

1 reference

28 August 2017

4

1 reference

28 August 2017

293-304

1 reference

https://scigraph.springernature.com/pub.10.1038/nrn3464

28 August 2017

0 references

cites work

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

On incentives for innovation.

21 January 2018

1 reference

Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study.

21 January 2018

1 reference

Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer

21 January 2018

1 reference

No paradox, no progress: inverse cancer comorbidity in people with other complex diseases

21 January 2018

1 reference

Parkinson's disease and cancer: two wars, one front

21 January 2018

1 reference

Medical disorders among inpatients with autism in Denmark according to ICD-8: a nationwide register-based study.

21 January 2018

1 reference

Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969-1993.

21 January 2018

1 reference

Cancer in schizophrenia: is the risk higher or lower?

21 January 2018

1 reference

Incidence of cancer among persons with schizophrenia and their relatives

21 January 2018

1 reference

Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates.

21 January 2018

1 reference

Breast cancer in women suffering from serious mental illness

21 January 2018

1 reference

Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009.

21 January 2018

1 reference

Cancer incidence in a sample of Maryland residents with serious mental illness

21 January 2018

1 reference

Cancer risk among parents and siblings of patients with schizophrenia.

21 January 2018

1 reference

Cancer risk in children with birth defects and in their families: a population based cohort study of 5.2 million children from Norway and Sweden

21 January 2018

1 reference

Cancers and immune related diseases associated with Down's syndrome: a record linkage study.

21 January 2018

1 reference

Incidence of leukemia and other cancers in Down syndrome subjects in Israel

21 January 2018

1 reference

Risks of leukaemia and solid tumours in individuals with Down's syndrome.

21 January 2018

1 reference

The profile and incidence of cancer in Down syndrome

21 January 2018

1 reference

Cancer linked to Alzheimer disease but not vascular dementia

21 January 2018

1 reference

Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study

21 January 2018

1 reference

Atypical cancer pattern in patients with Parkinson's disease.

21 January 2018

1 reference

Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies

21 January 2018

1 reference

Low cancer rates among patients with Parkinson's disease

21 January 2018

1 reference

Comorbid cancer in Parkinson's disease

21 January 2018

1 reference

Skin cancer in people with multiple sclerosis: a record linkage study

21 January 2018

1 reference

Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosis.

21 January 2018

1 reference

Cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.

21 January 2018

1 reference

Cancer risk among patients with multiple sclerosis: a population-based register study

21 January 2018

1 reference

Cancer risk in multiple sclerosis: findings from British Columbia, Canada

21 January 2018

1 reference

Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden

21 January 2018

1 reference

Preventing Alzheimer's disease

21 January 2018

1 reference

A reduced risk of Alzheimer's disease in those who survive cancer.

21 January 2018

1 reference

p53, a pivotal effector of a functional cross-talk linking presenilins and Pen-2.

21 January 2018

1 reference

Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration.

21 January 2018

1 reference

Inverse susceptibility to oxidative death of lymphocytes obtained from Alzheimer's patients and skin cancer survivors: increased apoptosis in Alzheimer's and reduced necrosis in cancer.

21 January 2018

1 reference

Alzheimer's failure raises questions about disease-modifying strategies

21 January 2018

1 reference

Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.

21 January 2018

1 reference

γ-Secretase inhibitor enhances antitumour effect of radiation in Notch-expressing lung cancer

21 January 2018

1 reference

Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis.

21 January 2018

1 reference

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance

21 January 2018

1 reference

Trade-off in the effect of the APOE gene on the ages at onset of cardiocascular disease and cancer across ages, gender, and human generations

21 January 2018

1 reference

MicroRNAs in neurodegenerative diseases and their therapeutic potential.

21 January 2018

1 reference

Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression

21 January 2018

1 reference

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

21 January 2018

1 reference

Cancer incidence in patients with schizophrenia and their first-degree relatives - a meta-analysis.

21 January 2018

1 reference

Phenopedia and Genopedia: disease-centered and gene-centered views of the evolving knowledge of human genetic associations

21 January 2018

1 reference

A census of human cancer genes

21 January 2018

1 reference

Mutated genes, pathways and processes in tumours

21 January 2018

1 reference

p53 at the crossroads between cancer and neurodegeneration

21 January 2018

1 reference

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

21 January 2018

1 reference

PTEN signaling in autism spectrum disorders

21 January 2018

1 reference

Differences in p53 gene polymorphisms between Korean schizophrenia and lung cancer patients.

21 January 2018

1 reference

Polymorphisms of XRCC4 are involved in reduced colorectal cancer risk in Chinese schizophrenia patients

21 January 2018

1 reference

Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia

21 January 2018

1 reference

A cytokine-dependent switch for glial-neuron interactions

21 January 2018

1 reference

Neuregulin-1 regulates cell adhesion via an ErbB2/phosphoinositide-3 kinase/Akt-dependent pathway: potential implications for schizophrenia and cancer

21 January 2018

1 reference

Increased LIS1 expression affects human and mouse brain development

21 January 2018

1 reference

Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis

21 January 2018

1 reference

Lis1 is essential for cortical microtubule organization and desmosome stability in the epidermis

21 January 2018

1 reference

Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease

21 January 2018

1 reference

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials

21 January 2018

1 reference

Why docosahexaenoic acid and aspirin supplementation could be useful in women as a primary prevention therapy against Alzheimer's disease?

21 January 2018

1 reference

The role of aspirin in cancer prevention

21 January 2018

1 reference

Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis.

21 January 2018

1 reference

Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions

21 January 2018

1 reference

Statin use and reduced cancer-related mortality

21 January 2018

1 reference

Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons

21 January 2018

1 reference

Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes

21 January 2018

1 reference

Stress- and allostasis-induced brain plasticity

21 January 2018

1 reference

Gut feelings: the emerging biology of gut-brain communication

21 January 2018

1 reference

Role of nervous system in cancer aetiopathogenesis

21 January 2018

1 reference

What is the brain-cancer connection?

21 January 2018

1 reference

The influence of bio-behavioural factors on tumour biology: pathways and mechanisms

21 January 2018

1 reference

Environmental and genetic activation of a brain-adipocyte BDNF/leptin axis causes cancer remission and inhibition

21 January 2018

1 reference

Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells

21 January 2018

1 reference

Neurotransmitters, more than meets the eye--neurotransmitters and their perspectives in cancer development and therapy

21 January 2018

1 reference

Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?

21 January 2018

1 reference

Colorectal cancer risk in relation to antidepressant medication use.

21 January 2018

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

Radium-223 chloride: a new treatment option for metastatic castration-resistant prostate carcinoma

21 January 2018

1 reference

Immunology. Neuroimmune communication

21 January 2018

1 reference

Cytokines and CNS development

21 January 2018

1 reference

Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit

21 January 2018

1 reference

Autoimmunity in psychiatry.

21 January 2018

1 reference

Paraneoplastic syndromes of the CNS.

21 January 2018

1 reference

CNS autoimmunity: new findings and pending issues

21 January 2018

1 reference

Cancer immunotherapy via dendritic cells

21 January 2018

1 reference

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

21 January 2018

1 reference

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

Night shift work, light at night, and risk of breast cancer

21 January 2018

1 reference

Circadian genes and breast cancer susceptibility in rotating shift workers

21 January 2018

1 reference

Night-shift work and risk of colorectal cancer in the nurses' health study

21 January 2018

1 reference

Carcinogenicity of shift-work, painting, and fire-fighting

21 January 2018

1 reference

Combined effects of methamphetamine and zolpidem on performance and mood during simulated night shift work

21 January 2018

1 reference

Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease

21 January 2018

1 reference

Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers.

21 January 2018

1 reference

Riding tandem: circadian clocks and the cell cycle

21 January 2018

1 reference

The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo

21 January 2018

1 reference

Altered sleep and behavioral activity phenotypes in PER3-deficient mice

21 January 2018

1 reference

Deletion of the PER3 gene on chromosome 1p36 in recurrent ER-positive breast cancer

21 January 2018

1 reference

A length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder.

21 January 2018

1 reference

Peripheral circadian oscillators: interesting mechanisms and powerful tools

21 January 2018

1 reference

Sleep and circadian rhythm disruption in schizophrenia

21 January 2018

1 reference

Impact of sunlight on the age of onset of bipolar disorder

21 January 2018

1 reference

Combined effects of melatonin and all-trans retinoic acid and somatostatin on breast cancer cell proliferation and death: molecular basis for the anticancer effect of these molecules

21 January 2018

1 reference

Drug Repurposing from an Academic Perspective

21 January 2018

1 reference

Phenothiazine: the seven lives of pharmacology's first lead structure

21 January 2018

1 reference

Discovery of very late antigen-4 (VLA-4, alpha4beta1 integrin) allosteric antagonists

21 January 2018

1 reference

Rapamycin passes the torch: a new generation of mTOR inhibitors

21 January 2018

1 reference

Rapamycin for treating Tuberous sclerosis and Autism spectrum disorders

21 January 2018

1 reference

Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice

21 January 2018

1 reference

ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models

21 January 2018

1 reference

Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice

21 January 2018

1 reference

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.

21 January 2018

1 reference

The pre-therapeutic classification of co-morbidity in chronic disease

21 January 2018

1 reference

Network medicine: a network-based approach to human disease

21 January 2018

1 reference

Trade-offs between cancer and other diseases: do they exist and influence longevity?

21 January 2018

1 reference

Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1

21 January 2018

1 reference

Risk for Cancer in Parents of Patients With Schizophrenia

21 January 2018

1 reference

Cancer incidence of persons with down syndrome in Finland: A population-based study

21 January 2018

1 reference

Cancer risk among patients with multiple sclerosis and their parents

21 January 2018

1 reference

21 January 2018

Final act of senescence

1 reference

Cancer risk in association with Parkinson disease: A population-based study

21 January 2018

1 reference

A decade for psychiatric disorders

21 January 2018

1 reference

The evolving war on cancer

21 January 2018

1 reference

Parkinson disease: Improving quality of care in Parkinson disease

31 March 2020

1 reference

Tumorigenesis in Down's syndrome: big lessons from a small chromosome

31 March 2020

1 reference

Schizophrenia and cancer: an epidemiological study

31 March 2020

1 reference

Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden

31 March 2020

1 reference

Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study

31 March 2020

1 reference

Mortality and cancer incidence in patients with Parkinson's disease

31 March 2020

1 reference

Increased melanoma risk in Parkinson disease: a prospective clinicopathological study

31 March 2020

1 reference

Cancer incidence in multiple sclerosis: a 35-year follow-up

31 March 2020

1 reference

Multiple sclerosis and cancer in Norway. A retrospective cohort study

31 March 2020

1 reference

Pin1: a new genetic link between Alzheimer's disease, cancer and aging.

31 March 2020

1 reference

Reduced expression of PER3 is associated with incidence and development of colon cancer

31 March 2020

1 reference

A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference

31 March 2020

2 references

31 March 2020

12 December 2020

The circadian clock and pathology of the ageing brain

1 reference

Regulation of circadian rhythms and hypothalamic-pituitary-adrenal axis: an overlooked interaction in cancer

31 March 2020

1 reference

MicroRNAs in cancers and neurodegenerative disorders

31 March 2020

1 reference

12 December 2020

Tumour immunogenicity: editorial selection demystified

1 reference

12 December 2020

Tumour immunotherapy — leukocytes take up the fight

1 reference

12 December 2020

Significantly lower incidence of cancer among patients with Huntington disease: An apoptotic effect of an expanded polyglutamine tract?

1 reference

12 December 2020

Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries

1 reference

12 December 2020

No association of amyotrophic lateral sclerosis with cancer

1 reference

12 December 2020

Neurobiological principles in the etiopathogenesis of disease: when diseases have a head.

1 reference

12 December 2020

Cellular senescence: a link between cancer and age-related degenerative disease?

1 reference

12 December 2020

Period3 structural variation: a circadian biomarker associated with breast cancer in young women.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRN3464

1 reference

PubMed ID

23511909

Dimensions Publication ID

28 August 2017

0 references

1 reference

PubMed ID

23511909